The role of infectious agents in pulmonary and systemic vascular disease

Bibliography

• HACK EC, VANDERPOLL T, LAMBERTUS TG (Eds.): The coagulation cascade in sepsis. Sepsis (1999) 3:85–182.
   Google Scholar
• ••This issue of the journal contains anumber of papers giving an up-to-date analysis of a complicated, rapidly evolving and clinically very important field.
   Google Scholar
• LOZINGUEZ O, ARNAUD E, BELEC L et al: Demonstration of an association between Chlmaydia pneumoniae infection and venous thromboembolic disease. Thromb. Haemost. (2000) 83:887–891.
   PubMedGoogle Scholar
• RATLIFF NB, MYLES JL: Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immune-mediated disease. Arch. Paha Lab. Med. (1989) 113:772–776.
   Google Scholar
• ROSENBERG RD, AIRD WC: Vascular bed specific hemostasis and hypercoagulable states. N. Engl. J. Med. (1999) 340:1555–1564.
   PubMed Web of Science ®Google Scholar
• ••A scholarly presentation of an interestinggeneral hypothesis.
   Google Scholar
• MOORE GW, SMITH RRL, HUTCHINS GM: Pulmonary artery atherosclerosis. Correlation with systemic atherosclerosis and hypertensive pulmonary vascular disease. Arch. Pathol Lab. Med. (1982) 106:378–380.
   Google Scholar
• FUJITA M, RUSSELL ME, MASEK M, ROWAN LA, NAGASHIMA K, BILLINGHAM PE: Graft vascular disease in the great vessels and vase vasorum. Hum. Paha (1993) 24:1067–1072.
   PubMedGoogle Scholar
• EGERMAYER P: Epidemics of pulmonary hyertension and vascular toxicity. What can be learned? J. Intern. Med. (2000) 247:11–17.
   Google Scholar
• ••Brief overview of environmental and toxic factors causing vascular disease, written from a historical perspective.
   Google Scholar
• RIDKER PM: Inflammation, infection, and cardiovascular risk. How good is the clinical evidence? Circulation (1998) 97:1671–1674.
   PubMed Web of Science ®Google Scholar
• ••Brief summary of the most important evidence.
   Google Scholar
• ROSS R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 362:801–809.
   PubMed Web of Science ®Google Scholar
• ••Definitive overview by a leading researcher.
   Google Scholar
• WEIS M, VON SCHEIDT W: Cardiac allograft vasculopathy. A review. Circulation (1997) 96:2069–2077.
   PubMed Web of Science ®Google Scholar
• SPEIR E, MODALI R, HUANG ES etal.:18.Potential role of human ctyomegalovirus and P53 interaction in coronary restenosis. Science (1994) 265:391–394.
   Google Scholar
• VERCOLLOTTI GM: Effects of viral•• activation of the vessel wall on19. inflammation and thrombosis. Blood Coagul Fibrilla (1998) 9\(Suppl. 2):53–6.
   Google Scholar
• GUETTA E, GUETTA V, SHIBUTANI T, EPSTEIN SE: Monocytes harboring cytomegalovirus: Interactions with endothelial cells, smooth muscele cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury. Circ. Res. (1997) 81:8–16.
   Google Scholar
• LIE JT: Thrombangitis obliterans (Buerger's disease) in women. Medicine (1986) 65:65–72.
   Google Scholar
• LOVEY PY, MORABIA A, BLEED D, PETER O, DUPUIS G, PETITE J: Long term vascular complications of Coxiella burrietii infection in Switzerland: cohort study. Br Med. J. (1999) 319:284–285
   PubMedGoogle Scholar
• ELGHETANY MT, WALKER DH: Hemostatic changes in Rocky Mountain Spotted Fever and Mediterannean Spotted Fever. Am. J. Clin. Pathol (1999) 112:159–168
   PubMed Web of Science ®Google Scholar
• IRUELA-ARISPE ML, DVORAK HF: Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb. Haemost. (1997) 78:672-677. Required reading.
   Google Scholar
• GILL P, AKIL B, COLLETTI P et al: Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. Am. j Med. (1989) 87:57–61.
   PubMed Web of Science ®Google Scholar
• •• One of very few studies of this subject.
   Google Scholar
• JAFFE HW, PELLETT PE: Human Herpesvirus 8 and Kaposfs sarcoma - some answers, more questions. N Engl. j Med. (2000) 340:1912–1913.
   Google Scholar
• STERLING GB: Kaposi's sarcoma and Castleman's disease. j. Am. Acad. Dermatal. (1990) 1:144
   Google Scholar
• SANTUCCI M, PIMPINELLI N, MORETTI S etal.: Classic and immunodeficiency-associated Kaposi's sarcoma. Clinical, histologic, and immunologic correlations. Arch. Pathol. Lab. Med. (1988) 112:1214–1220.
   Google Scholar
• UCCINI S, RUCO LE MONARDO F et al.: Co-experession of endothlial cell and macrophage antigens on Kaposi's sarcoma cells. J Pathol. (1994) 173:23–31.
   Google Scholar
• KIM TH, HIM HK, KANG JS, KIM JH, HWANG IY: Pseudo-Kaposi's sarcoma associated with acquired arteriovenous fistula. j. Dermatal. (1997) 24:28–33.
   PubMedGoogle Scholar
• RABKIN CS, JANZ S, LASH A et al.: Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl. j. Med. (1997) 336:988–993.
   PubMed Web of Science ®Google Scholar
• KOSTIANOVSKY M, GRECO MA: Angiogenic process in bacillary angiomatosis. Ultrastruc. Pathol. (1994) 18:349–355.
   PubMed Web of Science ®Google Scholar
• KAUFFMAN CL, HOLMAN RE HERBERT CR: Tender nodules and hyperpigmented plaques in a man with AIDS. The Aids Reader (2000) 10:41–44.
   Google Scholar
• ITIN PH, FLUCKIGER R, ZBINDEN R,FREI R: Recurrent pyogenic granuloma with satellosis- a localised variant of bacillary angiomatosis? Dermatology (1994) 189:409–412.
   PubMedGoogle Scholar
• HEATH D, READ R: Invasive pulmonaryhaemangiomatosis. Br j. Dis. Chest (1985) 79:284–294.
   PubMedGoogle Scholar
• SCHRAUFNAGEL DE, SEKOSAN M, MCGEE T et al: Human alveolar capillaries undergo angiogenesis in pulmonary veno-occlusive diease. Eur. Respir J. (1996) 9:346–350.
   PubMedGoogle Scholar
• MANDEL J, MARK EJ, HALES CA: State of the art. Pulmonary veno-occlusive disease. Am. j. Respir Grit. Care Med. (2000) 162:1964–1973.
   PubMedGoogle Scholar
• •• Up to the minute review of a rate butpathologically interesting disease.
   Google Scholar
• WELTON JC, MARR JS, SCHMIDT TM et al.: Association between hepatobiliary cancer and typhoid carrier state. Lancet (1979) 1:792–794.
   Google Scholar
• WITHERSPOON AC, DOGLIONI C, DISS TC et al.: Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet (1993) 342:575–577.
   PubMedGoogle Scholar
• JAMES DG: What makes granaulomas tick? Thorax (1991) 46:734–736
   PubMedGoogle Scholar
• Immunology of intracellular parasitism. Liew FY, Cox FEG (Eds.), Karger, Basel (1998):1–204.
   Google Scholar
• PURSLEY TV, JACOBSON RR: Lucio's phenomenon. Arch. Dermatal. (1980) 116:201–204.
   PubMedGoogle Scholar
• CHIMELLI L, FREITAS M, NASCIMENTO O: Value of nerve biopsy in the diagnosis and follow-up of leprosy, the role of vascular lesions and usefulness of nerve studies in the detection of persistent bacilli. j Neural (1997) 244:318–323.
   PubMedGoogle Scholar
• KIL A, LICTHMAN AH, FINBERG RW et al: Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP 60 activation of mononuclear cells. j. Immune]. (2000) 164:13–17.
   PubMedGoogle Scholar
• DUNNILL MS: Pulmonary granulomatosisand angiitis. Ilistaphathology (1991) 19:297–301.
   PubMedGoogle Scholar
• LUPI E, SANCHEZ G. HORWITZ S, GUTIERREZ E: Pulmonary involvement in Takayasu's arteritis. Chest (1975) 67:69–74.
   PubMed Web of Science ®Google Scholar
• ERKAN F, CAVDAR T: Pulmonary vasculitis in Behcet's diseaese. Am. Rev Respir. Dis. (1992) 146:232–239.
   PubMedGoogle Scholar
• YOKOI K, HOSOI E, AKAIKE M, SHIGEKIYO T, SATO S: Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases. Angiology (1996) 47:315–319.
   Google Scholar
• INA Y, TAKADA K, YAMAMOTO M, SATO T, ITO S, SATO S: Antiphospholipid antibodies. A prognostic factor in sarcoidosis? Chest (1994) 105:1179–1183.
   PubMed Web of Science ®Google Scholar
• COHEN TERVAERT JW, POPA FR, BOS NA: The role of superantigens in vasculitis. Curr. Opinion Rheumatal (1999) 11:24–33.
   PubMedGoogle Scholar
• MEHTA NJ, KHAN IA, MEHTA RN, SEPKOWITZ DA: HIV related pulmonary hypertension. Analytic review of 131 cases. Chest (2000) 118:1133–1141.
   Google Scholar
• GRAYSTON JT: Antibiotic treatment forChlamydia pneumoniae for secondary prevention of cardiovascular events. Circulation (1998) 97:1669–1670.
   PubMed Web of Science ®Google Scholar
• LANGFORD CA, HOFFMAN GS: Wegener's granulomatosis. Thorax (1999) 54:629-637. Informative overview, clinically orientated.
   Google Scholar
• ZABEL P, ENTZIAN P, DALHOFF K, SCHAAK KM: Pentoxifylline in treatment of sarcoidosis. Am. j. Respir. Grit. Care Med. (1997) 155:1665–1669.
   PubMed Web of Science ®Google Scholar
• SUSEN S, HAZZAN M, LABALETTE M eta].: Pentoxifylline prevents upregulation of monocyte tissue factor in renal transplant recipients undergoing post-graft complications. Thromb. Haemost. (2000) 84:764–769.
   Google Scholar
• FENNER H: TNF inhibitors: a new therapeutic perspective in chronic inflammatory disease in rheumatology. Z. Rheumatal (1995) 54:158–164.
   PubMedGoogle Scholar
• SHEPARD CC, ELLARD GA, LEVY L et al.: Experimental chemotherapy in leprosy. Bull WHO (1976) 53:425.
   PubMedGoogle Scholar
• LITTLE RE, WYVILL KM, PLUDA JM et al.: Activity of thalidomide in AIDS-related Kaposi's sarcoma. I Clin. Orical. (2000) 18:2593–2602.
   PubMed Web of Science ®Google Scholar
• WECK KE, DAL CANTO AJ, GOULD JD et al: Murine (-herpesvirus 68 causes severe large vessel arteritis in mice lacking interferon-( responsiveness: a new model for virus-induced vascular disease. Nature Med. (1997) 3:1346–1353.
   PubMed Web of Science ®Google Scholar
• HANSSON GK, HOLM J: Interferon-yinhibits arterial stenosis after injury. Circulation (1991) 84:1266–1272.
   PubMed Web of Science ®Google Scholar